ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 121-122
10.1002/hon.3163_82